# DBV Technologies (DBVT) — Overview

DBVT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/dbvt

## Price

Last close $9.11 on Oct 15, 2026. 52-week range $8.87 – $24.54.

## Company profile

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $5.0M |
| Revenue (quarter) | $700,000.00 |
| Revenue growth (year over year) | -53.33% |
| Gross profit (trailing twelve months) | $5.0M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$175.9M |
| Net income (quarter) | −$50.4M |
| Net income growth (year over year) | -20.29% |
| Net margin | -3493.78% |
| Return on equity | -142.68% |
| EPS (trailing twelve months) | −$3.50 |
| Book value per share | $2.71 |
| P/E (trailing twelve months) | — |
| Price to book | 3.4 |
| Debt to assets | 28.14% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is DBV Technologies (DBVT) profitable?

No. DBV Technologies reported a net loss of $175.9M over the trailing twelve months.

### How much revenue does DBV Technologies (DBVT) make?

DBV Technologies generated $5.0M in revenue over the trailing twelve months, down 53.33% year over year.

### How do I buy stock in DBV Technologies (DBVT)?

DBVT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).